Answers are grounded in this paper and cite their sources.
Background: This study assesses the retention rate of patients living with HIV in the antiretroviral treatment (ART) program at Donka the National Hospital, Guinea, and identifies predictors of non-retention. Methods: Conducted as a retrospective cohort study from May 2018 to March 2023, it involved 4,169 HIV-positive patients aged 10 and older, who had been on antiretroviral treatment program for at least six months. Retention rates were estimated using Kaplan-Meier techniques, and multivariate Cox regression identified factors associated with non-retention. Results: Results showed a cumulative retention rate of 68.88%, declining over time: 91.3% at six months, 74.1% at 24 months, and 53.1% at 60 months. The study identified significant predictors of non-retention, including low CD4 counts (<100 cells/mm³: adjusted HR 2.158; 100-200 cells/mm³: adjusted HR 1.729), advanced HIV stages (III/IV) at treatment initiation (adjusted HR 1.335), and the use of "AZT + 3TC + NVP" regimen (adjusted HR 1.443). Most participants were women (66.2%) with a median age of 37 years, and a majority were unemployed (57.8%). Conclusion: The findings highlight a retention rate below the national target of 90%, with late treatment initiation and low CD4 counts as major barriers. The study calls for further qualitative and quantitative research to understand patient loss to follow-up and improve ART program retention and HIV care in Guinea.
No takes yet. Share an insight, caveat, or question.
Leno et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: